PsyBio Therapeutics Augments Intellectual Property Portfolio

an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically...

BIONTECH, PSYBIO, BAYER: THE OPPORTUNITIES OF TOMORROW

BioNTech's vaccine could be a constant companion for people in the future...

PsyBio CEO to Present at Two Virtual Investor Conferences in June

OXFORD, Ohio and COCONUT CREEK, Fla., June 3, 2021 /PRNewswire/ -- PsyBio Therapeutics Corp. ..

Curevac, Psybio, Evotec- revolution in the Billion...

The anxiety and limitations associated with the coronavirus pose major....

PsyBio Therapeutics Reports First Quarter 2021 Financial Results

OXFORD, Ohio and COCONUT CREEK, Fla., June 1, 2021 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTC: PSYBF)...

Genetic Engineering & Biotechnology
News

Psilocybin mushrooms make tryptamines, which are responsible for their hallucinogenic effects, but also can be used...